CytoMed Therapeutics Ltd (GDTC)
2.11
-0.02
(-0.94%)
USD |
NASDAQ |
May 17, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
CytoMed Therapeutics Shareholders Equity (Quarterly): 8.514M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.514M |
| June 30, 2023 | 9.710M |
| June 30, 2023 | 9.710M |
| December 31, 2022 | 0.4377M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.120M |
| June 30, 2022 | 1.120M |
| December 31, 2021 | 1.917M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.4377M
Minimum
Dec 2022
9.710M
Maximum
Jun 2023
4.647M
Average
1.917M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Haw Par Corp Ltd | 2.632B |
| WAVE Life Sciences Ltd | 25.39M |
| ASLAN Pharmaceuticals Ltd | -17.96M |
| EUDA Health Holdings Ltd | -5.990M |
| Mobile-health Network Solutions | -0.3672M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.365M |
| Total Liabilities (Quarterly) | 0.8515M |